Objectives The role of health-related quality of life (HRQoL) and psychological variables in
pulmonary arterial hypertension (PAH) progression remains poorly quantified. We aimed to …

Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that
negatively impacts health‐related quality of life (HRQOL). The PAH‐symptoms and impact …

Background. Health‐related quality of life (HRQoL) impairment is common in pulmonary
hypertension (PH), but its clinical predictors are not well established. This study aims to …

Background Improvement in quality of life together with better survival are the ultimate goals
in the treatment of pulmonary arterial hypertension (PAH) patients. The objective of this …

BACKGROUND: Pulmonary arterial hypertension (PAH) remains a debilitating and life-
threatening disease despite improvements in hemodynamics, exercise capacity and survival …

Background: Pulmonary arterial hypertension (PAH) is a chronic illness that impairs physical
function and leads to right-sided heart failure and premature death. There is limited …

The Pulmonary Arterial Hypertension Symptoms and Impact Questionnaire (PAH-
SYMPACT) is a PAH-specific patient-reported outcome scale assessing patients' quality of …

Objective Pulmonary arterial hypertension (PAH) is a rare and life-threatening disease well-
marked by under diagnosis, delayed diagnosis and atypical treatments. Few data are …

BACKGROUND Health-related quality of life (HRQoL) is severely impaired in pulmonary
arterial hypertension (PAH). We aimed to assess the effect of PAH-specific therapies on …

Health-related quality of life (HRQoL) scores assess symptom burden in pulmonary arterial
hypertension (PAH) but data regarding their role in prognostication and risk stratification are …